Status:
COMPLETED
Effect of PVE on Surgical Outcomes and Long-term Survival in Perihilar Cholangiocarcinoma
Lead Sponsor:
Seoul National University Hospital
Conditions:
Biliary Tract Cancer
Portal Vein Embolization
Eligibility:
All Genders
Brief Summary
Portal vein embolization is often recommended to reduce the risk of postoperative liver failure and mortality. In this retrospective cohort study, researchers investigated the effect of portal vein em...
Eligibility Criteria
Inclusion
- patients with Bismuth type III or IV stricture on radiological examination, including computed tomography (CT) or magnetic resonance cholangiography
- patients with perihilar cholangiocarcinoma histologically confirmed by surgical resection or forceps biopsy/brush cytology under endoscopic retrograde cholangiopancreatography or through the percutaneous transhepatic biliary drainage tract.
Exclusion
- patients with unresectable perihilar cholangiocarcinoma
- patients who refused treatment
- patients with other concomitant malignancies.
Key Trial Info
Start Date :
January 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT06222619
Start Date
January 30 2020
End Date
August 30 2023
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080